Purinostat (mesylate)
Purinostat mesylate is a selective inhibitor of HDAC. Purinostat mesylate inhibits class I and class IIb HDACs with IC50s from 0.81 to 11.5 nM. Purinostat mesylate induces apoptosis and affects cell cycle of LAMA84 and 188 BL-2 cells, and shows potently anti-leukemia effects in vivo. Purinostat mesylate can be used for the research of lymphoblastic leukemia[1].
Product Specifications
CAS Number
2650188-32-0
UNSPSC
12352005
Target
Apoptosis; HDAC
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/purinostat-mesylate.html
Purity
99.45
Solubility
DMSO : 35 mg/mL (ultrasonic)
Smiles
O=C(C1=CN=C(N(CC2=NC3=C(N4CCOCC4)N=C(C5=CC=C(N)C=C5)N=C3N2C)C)N=C1)NO.O=S(O)(C)=O
Molecular Formula
C24H30N10O6S
Molecular Weight
586.62
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![UBE2C Recombinant Rabbit Monoclonal Antibody [JE38-67]](https://cdn.genprice.uk/products/992/68dd1c8c061270361ea819fd/imageurl/ha722454.webp)
UBE2C Recombinant Rabbit Monoclonal Antibody [JE38-67]
Cytokeratin 15 (Esophageal Squamous Cell Carcinoma Marker) (KRT15/2103R), CF568 conjugate, 0.1mg/mL
